Vitamin C supplementation showed greater effects on systolic blood pressure in hypertensive and diabetic patients: an updated systematic review and meta-analysis of randomised clinical trials

Int J Food Sci Nutr. 2023 Dec;74(8):814-825. doi: 10.1080/09637486.2023.2264549. Epub 2023 Dec 12.

Abstract

Results from randomised controlled trials (RCTs) testing the effect of vitamin C supplementation on blood pressure (BP) have been inconsistent. This systematic review evaluated the effects of vitamin C supplementation on BP and included RCTs testing the effects of vitamin C supplementation alone, on systolic and diastolic BP in adult participants (≥18 years). Random-effect models were conducted to estimate the pooled effects of vitamin C supplementation on BP. A total of 20 studies with 890 participants were included. The median dose of vitamin C was 757.5 mg/d, the median duration was 6 weeks. Vitamin C supplementation was found to reduce systolic BP by -3.0 mmHg (95%CI: -4.7, -1.3 mmHg; p = 0.001). Subgroup analysis showed a more pronounced effect on systolic BP in patients with hypertension (-3.2 mmHg, 95%CI -5.2, -1.2 mmHg, p = 0.002) and diabetes (-4.6 mmHg, 95%CI -8.9, -0.3 mmHg, p = 0.03). Further research needs to evaluate the long-term effect of vitamin C on BP in populations with impaired cardio-metabolic health.

Keywords: Vitamin C; blood pressure; hypertension.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Adult
  • Ascorbic Acid / therapeutic use
  • Blood Pressure
  • Diabetes Mellitus* / drug therapy
  • Dietary Supplements
  • Humans
  • Hypertension* / drug therapy
  • Randomized Controlled Trials as Topic
  • Vitamins / pharmacology

Substances

  • Vitamins
  • Ascorbic Acid